Company / Depreciation & Amortization
Nurix Therapeutics, Inc. Depreciation & Amortization History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$8.7M
FY2025
5-year range
$2.4M / $9.3M
FY2021-FY2025
Trend
-6.2%
vs FY2024
Sector context
#68 of 163
Health Care
What the data says
At $9M, Nurix Therapeutics, Inc.'s depreciation & amortization ranks #96 of 163 in the Health Care sector. Increased from $8M to $9M over the past 2 years.
Based on SEC 10-K filings.
$9M in FY2025 with a 5-year CAGR of +32.0%.
Increased from $8M to $9M over the past 2 years.
Health Care sector context is included.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- +46.3%
- 5-Year CAGR
- +32.0%
- 10-Year CAGR
- -
Sector benchmark
#96 of 163 in Health CareTop 58% of 163This company $8.7M Sector average $219.4M
▼
-96.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +32.0%, indicating consistent growth.
- In FY2025, depreciation & amortization decreased 6.2% year-over-year.
- Ranks #68 out of 163 companies in the Health Care sector.
- Peak depreciation & amortization was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.35 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $8.7M | -6.2% |
| FY2024 | $9.3M | +23.7% |
| FY2023 | $7.5M | +170.0% |
| FY2022 | $2.8M | +18.5% |
| FY2021 | $2.4M | +8.0% |
| FY2020 | $2.2M | -7.4% |
| FY2019 | $2.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026